| Bioactivity | SARS-CoV-2-IN-62 (Compound R3b) is an inhibitor of SARS-CoV-2 replication and has low cytotoxicity. SARS-CoV-2-IN-62 inhibits viral replication in Vero E6 cells and Calu-3 cells, with EC50 values of 2.97 μM and 3.82 μM, respectively[1]. |
| Name | SARS-CoV-2-IN-62 |
| CAS | 2350285-18-4 |
| Formula | C17H21N3O3Se |
| Molar Mass | 394.33 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Tucci AR, et al. Antiviral Effect of 5'-Arylchalcogeno-3-aminothymidine Derivatives in SARS-CoV-2 Infection. Molecules. 2023 Sep 19;28(18):6696. |
SARS-CoV-2-IN-62
CAS: 2350285-18-4 F: C17H21N3O3Se W: 394.33
SARS-CoV-2-IN-62 (Compound R3b) is an inhibitor of SARS-CoV-2 replication and has low cytotoxicity. SARS-CoV-2-IN-62 inh
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.